Clinically related documents
Jan Hed, Clin Immunologist, MD, PhD
Karolinska Institutet, IMPI, Div of Clin Immunology
Huddinge University Hospital, Sweden
The statements below are based on conclusions from selected publications. Their intention is to highlight recent research and information that could be beneficial in allergy in vitro testing. They can include seemingly contradictory statements due to differences in selecting patient populations as well as in the study design.
- Peanut is one of the most allergenic food known. Peanut allergy is seldom outgrown, and allergic reactions are often acute and severe (1).
- A high cross-reactivity exists in legume-allergy between peanut, soy, lentils and beans (2, 3), but is often not confirmed with challenge studies (3, 4).
- There is a close relation between sensitization to soy and peanut (70%) in children with food intolerance, but the clinical sensitivity to soy is rather rare (5).
- In a population of atopic children only 6 % had a positive skin test to soy and 20% of these had a positive challenge test, indicating that soy allergy is not common in atopic children (6). In a similar study, the corresponding values were 21% for a positive skin test and 6% for a positive challenge test (7).
- Early sensitization to peanut can occur through milk formulas that contain peanut oil (8,9). Patients react to crude peanut oil, but not to refined peanut oil (10, 11).
- The incidence of history-based allergy to soy protein formulas (SPF) is 27% but in challenge studies, only 3-4% of the patients taking SPF gave a positive reaction (12).
- The major allergen of peanut is easily released in the mouth and, like other legume allergens, has a high natural resistance to thermal, chemical and proteolytic denaturation (13).
- Peanut allergy is a common phenomenon (23%) in individuals monosensitized to grass (14), but not in individuals monosensitized to birch (tree) (15) or mugwort (weed) (16).
- Cross-reactive IgE directed to carbohydrate determinants of grass pollen and peanut has been found and is believed to have poor biological activity (17).
- The prevalence of peanut sensitization at 4 years of age is around 1% and about half of these have clinical symptoms (18).
- The first clinical reaction to peanut occurs at home before 2 years of age (19,20,21) and seldom after 17 years of age (22). In most patients (>70%) the reaction was believed to result from the first exposure (19, 23).
- Persistent peanut allergy is more common in patients with other food allergies (20).
- Severe symptoms are more common in adults (23) and often coexist with tree-nut allergy (21). One third of peanut allergic patients were also sensitized to tree-nuts in one study (19).
- Peanut IgE > 15 kU/l in a highly atopic population predict (>95%) clinical reaction at exposure and eliminate the need to perform food challenge tests (24).
- Peanut sensitization is common, together with wheat and tree nut sensitizatin, in exercise-induced asthma (25).
- Epidemics of asthma have occurred in relation to inhalation of soy dust from unloading grain silo (26).